Company intelligence / Profile preview

TTAM Research Institute

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

TTAM Research Institute operates the former 23andMe Personal Genome Service and Research Services, continuing to provide consumer DNA/genetic testing and maintain industry-leading genetic research databases; the organization is transitioning these programs from a for-profit to nonprofit, public benefit context, aiming to expand participant-driven genetics research and personalized insights

Therapeutic areas: Rare Diseases
Modalities: DNA testingGenomic analysisGenetic data platform
Industry: Academic Hospital/University/Research

Partnerships

None specifically disclosed since nonprofit transition

Beyond the preview

Go deeper on TTAM Research Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TTAM Research Institute.

Explore the full profile